Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 47 937.8 |
96 | EP file number | EAKZ | 10 01 0411.6 |
97 | EP publication number | EPN | 2301524 |
54 | Designation/title | TI | Inhalierbares Aztreonam ohne Arginine zur Behandlung und Vorbeugung von bakteriellen Lungeninfektionen |
51 | IPC main class | ICM (ICMV) | A61K 9/12 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/427 (2006.01), A61P 11/00 (2006.01) |
22 | DE application date | DAT | Dec 20, 2001 |
96 | EP application date | EAT | Dec 20, 2001 |
43 | Date of first publication | OT | Mar 30, 2011 |
| Date of publication of grant | PET | Apr 24, 2013 |
71/73 | Applicant/owner | INH | Gilead Sciences, Inc., Foster City, Calif., US |
72 | Inventor | IN | Montgomery, Alan Bruce, Bellevue, WA 98030, US |
74 | Representative | VTR | LOUIS, PÖHLAU, LOHRENTZ, 90409 Nürnberg, DE |
| Address for service | | Patent- und Rechtsanwälte Louis, Pöhlau, Lohrentz, 90014 Nürnberg, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 258423 P Dec 27, 2000
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002301524 Searchable text:
EP000002301524 Original document:
EP000002301524B1 Searchable text:
EP000002301524B1 |
43 | Date of first publication | EVT | Mar 30, 2011 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 30, 2022 (Show all update days)(Hide all update days)- May 27, 2011
- Date of the first transfer into DPMAregister
|